Premenopausal advantages in postprandial lipid metabolism are lost in women with type 2 diabetes
Premenopausal advantages in postprandial lipid metabolism are lost in women with type 2 diabetes
Objective: Women with type 2 diabetes appear to lose the protection against cardiovascular disease afforded by estrogens. We examined the effects of menopausal status on postprandial clearance of dietary fat in healthy and diabetic women.
Research Design and Methods: Fasting subjects (premenopausal and postmenopausal control subjects, premenopausal and postmenopausal diabetic women, all n = 8) were given a meal containing the stable isotope 1,1,1-13C-tripalmitin, with blood and breath sampled for 6 and 24 h, respectively, in the postprandial period. Lower levels of 13C-palmitic acid (13C-PA) in the triglyceride fraction implies more efficient chylomicron clearance, lower levels of 13C-PA in the nonesterified fatty acid (NEFA) fraction implies improved dietary NEFA entrapment, and higher levels of 13CO2 in the breath denote more efficient of oxidation of dietary-derived lipid.
Results: In diabetic women, there were no differences between the pre- and postmenopausal groups for any of these parameters. In contrast, premenopausal control subjects, compared with postmenopausal control subjects, had lower 13C-PA in the triglyceride fraction area under the curve (AUC) (premenopausal median [range] 25.2 [12.1–49.4 mmol/l] per 6 h, postmenopausal 48.5 [15.5–77.2 mmol/l] per 6 h; P < 0.01) and higher 13CO2 levels in the breath AUC (premenopausal 22.5 [18.0–31.5%] of administered dose, postmenopausal 17.2 [11.2–31.5%] of administered dose; P < 0.01) with no difference between groups in levels of 13C-PA in the NEFA fraction AUC.
Conclusions: The premenopausal advantage in clearance of dietary lipid is not seen in premenopausal diabetic women. This is likely to promote an atherogenic lipoprotein profile and may contribute to the loss of cardiovascular disease protection seen in diabetic women.
3243-3249
Masding, Michael G.
7e97128a-ec98-4205-9dd7-ce52f01cd79b
Stears, Anna J.
26819ea8-7b55-41a2-a99a-6077d1008fe2
Burdge, Graham C.
09d60a07-8ca1-4351-9bf1-de6ffcfb2159
Wootton, Stephen A.
bf47ef35-0b33-4edb-a2b0-ceda5c475c0c
Sandeman, Derek D.
9a01dfb1-c2b5-46cc-a64c-b76677f4cfd6
December 2003
Masding, Michael G.
7e97128a-ec98-4205-9dd7-ce52f01cd79b
Stears, Anna J.
26819ea8-7b55-41a2-a99a-6077d1008fe2
Burdge, Graham C.
09d60a07-8ca1-4351-9bf1-de6ffcfb2159
Wootton, Stephen A.
bf47ef35-0b33-4edb-a2b0-ceda5c475c0c
Sandeman, Derek D.
9a01dfb1-c2b5-46cc-a64c-b76677f4cfd6
Masding, Michael G., Stears, Anna J., Burdge, Graham C., Wootton, Stephen A. and Sandeman, Derek D.
(2003)
Premenopausal advantages in postprandial lipid metabolism are lost in women with type 2 diabetes.
Diabetes Care, 26 (12), .
(doi:10.2337/diacare.26.12.3243).
Abstract
Objective: Women with type 2 diabetes appear to lose the protection against cardiovascular disease afforded by estrogens. We examined the effects of menopausal status on postprandial clearance of dietary fat in healthy and diabetic women.
Research Design and Methods: Fasting subjects (premenopausal and postmenopausal control subjects, premenopausal and postmenopausal diabetic women, all n = 8) were given a meal containing the stable isotope 1,1,1-13C-tripalmitin, with blood and breath sampled for 6 and 24 h, respectively, in the postprandial period. Lower levels of 13C-palmitic acid (13C-PA) in the triglyceride fraction implies more efficient chylomicron clearance, lower levels of 13C-PA in the nonesterified fatty acid (NEFA) fraction implies improved dietary NEFA entrapment, and higher levels of 13CO2 in the breath denote more efficient of oxidation of dietary-derived lipid.
Results: In diabetic women, there were no differences between the pre- and postmenopausal groups for any of these parameters. In contrast, premenopausal control subjects, compared with postmenopausal control subjects, had lower 13C-PA in the triglyceride fraction area under the curve (AUC) (premenopausal median [range] 25.2 [12.1–49.4 mmol/l] per 6 h, postmenopausal 48.5 [15.5–77.2 mmol/l] per 6 h; P < 0.01) and higher 13CO2 levels in the breath AUC (premenopausal 22.5 [18.0–31.5%] of administered dose, postmenopausal 17.2 [11.2–31.5%] of administered dose; P < 0.01) with no difference between groups in levels of 13C-PA in the NEFA fraction AUC.
Conclusions: The premenopausal advantage in clearance of dietary lipid is not seen in premenopausal diabetic women. This is likely to promote an atherogenic lipoprotein profile and may contribute to the loss of cardiovascular disease protection seen in diabetic women.
Text
3243.pdf
- Version of Record
Restricted to Repository staff only
Request a copy
More information
Published date: December 2003
Identifiers
Local EPrints ID: 25797
URI: http://eprints.soton.ac.uk/id/eprint/25797
ISSN: 1935-5548
PURE UUID: 8a53bbe4-bbd1-4cb0-b0c0-0d299ba17dc8
Catalogue record
Date deposited: 19 Apr 2006
Last modified: 15 Mar 2024 07:05
Export record
Altmetrics
Contributors
Author:
Michael G. Masding
Author:
Anna J. Stears
Author:
Derek D. Sandeman
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics